درباره این اپیزود
A strong drug diversion program shouldn't just help you investigate what already happened. It should help you identify risk earlier and give your team the information needed to act.
In this episode of Drug Diversion Insights, Rick Couldry, Chief Pharmacy and Clinical Officer at Omnicell, and Jay Patel, Product Manager for Diversion Management, join us to explore how healthcare organizations can move from reactive diversion investigations toward a more proactive, connected approach to diversion management.
Drug diversion programs generate enormous amounts of data, but data alone doesn't create visibility. The challenge is connecting information across medication workflows, identifying meaningful patterns, and turning those patterns into actionable insights.
Rick and Jay discuss what changes when diversion management becomes part of a broader medication-management ecosystem rather than operating as another isolated point solution.
In this episode, we discuss:
- Why healthcare drug diversion remains difficult to detect proactively
- How connected medication data can strengthen diversion monitoring
- Turning diversion data into actionable insights
- The role of technology in supporting diversion investigations
- Why integration across medication-management workflows matters
- Omnicell's approach to Diversion Management
- How Diversion Management fits into Omnicell's broader medication-management strategy
- OmniSphere and the future of connected medication management
The conversation also looks at OmniSphere, Omnicell's cloud-native platform, and what a more connected medication-management environment could mean for diversion teams.
For healthcare organizations, the goal isn't simply to collect more data. It's to make that data more useful.
Can connected systems provide the visibility needed to recognize potential diversion patterns sooner? Can analytics help teams focus limited investigative resources on the activity that matters most? And how can technology become part of a comprehensive diversion strategy that brings together people, processes, governance, and data?
This episode is for pharmacy leaders, drug diversion specialists, medication safety professionals, compliance teams, nursing leaders, risk management professionals, healthcare executives, and health system technology leaders looking for ways to strengthen controlled substance oversight and move their diversion programs from reactive to proactive.
Drug Diversion Insights is presented by Rxpert Solutions, bringing together healthcare leaders and industry experts to examine the challenges, strategies, and technologies shaping drug diversion prevention and medication safety.
